Patent intelligence · US
US 11059907
Antibodies that bind Notum Pectinacetylesterase
Antibodies that bind Notum Pectinacetylesterase
Patent details — US 11059907
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 13, 2021
- Expiration
- Jul 8, 2041
- Applicant
- LEXICON PHARMACEUTICALS, INC.
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61P
Quick answer
US 11059907 (Antibodies that bind Notum Pectinacetylesterase) is held by LEXICON PHARMACEUTICALS, INC.. Status: granted. Granted Jul 13, 2021. Expires Jul 8, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- LEXICON PHARMACEUTICALS, INC.
- Grant date
- Expiration
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61P, A61P19/00, A61P19/08
More from LEXICON PHARMACEUTICALS, INC.
Related pharmaceutical patents in our USPTO index.
-
US 12344596
Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof
granted -
US 11730723
Compounds and methods for treating viral infections
granted -
US 11666575
Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral infections
granted -
US 10106569
Inhibitors of sodium glucose transporter 1 for constipation
granted -
US 9862724
Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
granted -
US 9688710
Inhibitors of sodium glucose cotransporter 1
granted -
US 9682982
Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use
granted
Frequently asked questions
What is US patent 11059907?
US 11059907 (Antibodies that bind Notum Pectinacetylesterase) is held by LEXICON PHARMACEUTICALS, INC.. Status: granted. Granted Jul 13, 2021. Expires Jul 8, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11059907?
LEXICON PHARMACEUTICALS, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 102 pharmaceutical patents for this assignee.
When does US 11059907 expire?
Our index shows an expiration date of Jul 8, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.